Certified by Founder Lodge
Verismo Therapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $7,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignanc
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 01 ,2023 | Pre Series A | $7,000,000 | |
| July, 19 ,2023 | Seed | $6,000,000 |
BRV Capital Management
Ignite Innovations
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Tesoro XP, Inc. | $5,400,000 | (Jan 7, 2026)
dazzle ai | $8,000,000 | (Jan 7, 2026)
Truemed | $34,000,000 | (Jan 7, 2026)
Lucidean | $18,000,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)
